Gleiss Lutz advises DMB Deutsche Mittelstand Beteiligungen on sale of Angiokard Mediz-intechnik to Lohmann & Rauscher

A team of Gleiss Lutz lawyers has advised DMB Deutsche Mittelstand Beteiligungen, a holding based in Hamburg, in relation to the sale of Angiokard. The buyer is Lohmann & Rauscher (L&R) Group.

Since its formation in 1986, Angiokard Medizintechnik GmbH has been producing and distributing customer-specific kits for cardiology, anaesthesia, angiography, heart surgery and intensive care. Given its more than 30 years of experience in the industry, the German company with 132 employees and registered office in Friedeburg, Lower Saxony is a well-regarded supplier, particularly in Germany, where it holds a strong market position.

DMB is a holding based in Hamburg that focuses on profitable SMEs in Germany, Austria and Switzerland. DMB initiates and structures majority equity holdings in companies with a corporate value of up to 50 million euros.

The following Gleiss Lutz team advised DMB on the transaction: Dr. Patrick Mossler (partner, lead), Dr. Daniel Heck (counsel), Dr. Mathias Boas-Knecht, Sebastian Dietz (all Hamburg), Dr. Julia Müller (Frankfurt, all M&A), Dr. Moritz Holm-Hadulla (partner, Stuttgart), Dr. Kristina Winkelmann (Brussels, both Competition/Antitrust).